Westbrook - ARTEL and IonGate Biosciences announced their strategic partnership to support the growing application of IonGate’s drug discovery technology. The German biotechnology company will leverage ARTEL’s local infrastructure, customer relationships and market knowledge to increase the exposure and use of its discovery systems and assay development services in North America. The partnership will focus on IonGate’s SURFE²R Technology, which enables more effective research involving drug targets such as membrane transporters and ligand-gated ion channels.

Frankfurt / Main - IonGate Biosciences GmbH will present relevant application fields for the proprietary SURFE²R Technology (SURFace Electrogenic Event Reader) at the SBS Symposium “Label Free Technologies in Drug Discovery” in Dresden, Germany. The meeting is being held at the international congress center on June 10 – 11.

Visit us at the following events:

DDT - Drug Discovery & Development of Innovative Therapeutics
IBC's 13th Annual World Congress

August 4 -7, 2008
World Trade Center Boston
Boston, USA
Booth # 513
[congress homepage] 

We showcase the new SURFE²R Workstation.

As a winner of the contest "365 Landmarks in the Land of Ideas" IonGate will celebrate the award with an "Open House" on Monday, November 17, 2008.

[Read more]